JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to debt ceiling.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| BRIAN BURNS | — |
| DARREL C JODREY | — |
| CHARLES NAU | — |
| MARK REESE | — |
Consumer Issues/Safety/Products CSP
- Issues related to dextromethorphan. - Issues related to pseudoephedrine. - Issues related to the regulation of cosmetic products. - HR 1385, "Safe Cosmetics and Personal Care Products Act of 2013", regarding all provisions.- S 644/ HR 3969, "Preventing Abuse of Cough Treatments Act of 2013", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREL C JODREY | — |
Trade (domestic/foreign) TRD
- Issues related to current and future trade negotiations. - Issues related to TransPacific Partnership trade negotiations. - Issues related to TransAtlantic Trade and Investment Partnership negotiations. - Issues related to Trade Promotion Authority.- Issues related to dedicated USG healthcare trade position.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Manufacturing MAN
S 1709, "American Manufacturing Competitiveness Act of 2013", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK REESE | — |
Financial Institutions/Investments/Securities FIN
- HR 1135, "Burdensome Data Collection Relief Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Copyright/Patent/Trademark CPT
- Issues related to patent reform. - S 712, "Patents for Humanity Program Improvement Act of 2013", regarding all provisions. - "Targeting Rogue Opaque Letters Act of 2014", regarding all provisons (no bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES NAU | — |
Health Issues HCR
- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895/ S 2902, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs. - Issues related to combination products. - Issues related to the PROTECT Act (bill number pending), specifically medical mobile applications. - Issues related to Government Health Care Exclusion/ Debarment (bill number pending)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| GREGORY ARONIN | — |
| BRIAN BURNS | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
| CHARLES NAU | — |
| MARK REESE | — |
Medicare/Medicaid MMM
- Issues related to Medicare reimbursement for Clinical Laboratory Services. - HR 8, "American Taxpayer Relief Act of 2012", regarding all provisions in Section 636. - HR 800, "To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare", regarding all provisions.- Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues related to implantable medical devices. - Issues related to diabetes care products. - Issues related to competitive bidding of diabetes care products. - Issues related to health care pricing transparency. - Issues related to OIG study regarding competitive bidding. - Issues related to the CMS proposed rule regarding Medicare Part D and 6 protected classes. - S 1871, "SGR Repeal and Medicare Beneficiary Access Act of 2013", regarding all provisions. - PL 111-148, "Patient Protection and Affordable Care Act", regarding provisons related to the sustainable growth rate. - Issues related to 340B payments to hospitals. - HR 5644/ S 2689, "Medicare CGM Access Act of 2014", regarding all provisions. - HR 4302/ PL 113-93, "Protecting Access to Medicare Act of 2014", regarding implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| BRIAN BURNS | — |
| LAURYL DODSON JACKSON | — |
| MARK REESE | — |
Environment/Superfund ENV
- S.1009, "Chemical Safety Improvement Act", regarding all provisions. - Ortho Clinical Diagnostics liability issue related to the EPA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| DARREL C JODREY | — |
Taxation/Internal Revenue Code TAX
- Issues regarding tax reform. - HR 1248, "Family Health Care Flexibility Act", regarding all provisions. - Issues related to tax legislation. - Issues related to Ways and Means and Senate Finance tax reform discussion drafts.- HR 1129 / S 1645, "Mobile Workforce State Income Tax Simplification Act of 2013", regarding all provisions. - HR 2992, "Business Activity Tax Simplification Act", regarding all provisions. - HR 2835, "Restoring Access to Medication Act", regarding all provisions. - Issues related to OECD tax project.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| GREGORY ARONIN | — |
| BRIAN BURNS | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.